NCT01007292 2015-10-19A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior TreatmentAstellas Pharma IncPhase 2 Completed43 enrolled
NCT00818480 2015-09-04An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155Astellas Pharma IncPhase 2 Completed10 enrolled